A study to evaluate the effectiveness and safety of tirzepatide injection in patients with type 2 diabetes (UMIN-CTR) - Oct 25, 2026 - P=N/A | N=100 | Completed | Sponsor: Meitetsu hospital
New trial • Real-world evidence • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
|